1265822-30-7
Chemical Structure
CTA056
- CAS No.: 1265822-30-7
- Formula:C35H34N6O
- Molecular Weight:554.68
IUPAC Name: 7-benzyl-1-(3-(piperidin-1-yl)propyl)-2-(4-(pyridin-4-yl)phenyl)-1,5-dihydro-6H-imidazo[4,5-g]quinoxalin-6-one
InChIKey: BSSBAJKNZOHHCA-UHFFFAOYSA-N
SMILES: O=C1C(CC2=CC=CC=C2)=NC3=C(N1)C=C(N=C4C5=CC=C(C6=CC=NC=C6)C=C5)C(N4CCCN7CCCCC7)=C3
Biological Activity: CTA056 is an ITK (IL-2-inducible T-cell kinase) inhibitor with an IC50 of 0.1 μM. CTA056 selectively targets malignant T cells and modulates oncomirs. CTA056 induces apoptosis and is a potential therapeutic agent for the research of T-cell leukemia and lymphoma[1].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
CTA056 | CTA056 is an ITK (IL-2-inducible T-cell kinase) inhibitor with an IC50 of 0.1 μM. CTA056 selectively targets malignant T cells and modulates oncomirs. CTA056 induces apoptosis and is a potential therapeutic agent for the research of T-cell leukemia and lymphoma. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
Keywords
